TargetMol

Ioforminol

Product Code:
 
TAR-T32177
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T32177-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Ioforminol, also known as GE-145 and AN-113111, is a new low-osmolar dimeric radiographic contrast agent. GE-145 exhibits similar preclinical properties to other dimeric radiographic contrast media. In addition, the low osmolality enables an iso-osmolar formulation containing a significantly higher concentration of electrolytes than Visipaque.
CAS:
1095110-48-7
Formula:
C33H40I6N6O15
Molecular Weight:
1522.137
Purity:
0.98
SMILES:
OCC(O)CNC(=O)c1c(I)c(N(CC(O)CN(C=O)c2c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c2I)C=O)c(I)c(C(=O)NCC(O)CO)c1I

References

1. Wistrand LG, Rogstad A, Hagelin G, Roed L, Oulie I, Gram A, Evans P, Rasmussen H, Grant D, Iveson P, Newton B, Thaning M. GE-145, a new low-osmolar dimeric radiographic contrast medium. Acta Radiol. 2010 Nov;51(9):1014-20. doi: 10.3109/02841851.2010.509739. PubMed PMID: 20849319. 2. Chai CM, Rasmussen H, Eriksen M, Hvoslef AM, Evans P, Newton BB, Videm S. Predicting cardiotoxicity propensity of the novel iodinated contrast medium GE-145: Ventricular fibrillation during left coronary arteriography in pigs. Acta Radiol. 2010 Nov;51(9):1007-13. doi: 10.3109/02841851.2010.504743. PubMed PMID: 20799918.